Gregory Madison

Gregory Madison

Corporate Officer/Principal bij PROKIDNEY CORP.
59 jaar
Health Technology
Health Services
Consumer Services

Profiel

Gregory Paul Madison is currently Director at Phosphate Therapeutics Ltd. since 2021, Trustee at American Kidney Fund, Inc., and Chief Commercial Officer at ProKidney Corp.
starting in 2026.
Former roles include President, Chief Executive Officer & Director at Keryx Biopharmaceuticals, Inc. from 2015 to 2018; President, Chief Executive Officer & Director at Melt Pharmaceuticals, Inc.; Group Chief Executive Officer & Director at Shield Therapeutics Plc from 2021 to 2024; Director at Kidney Care Partners; Vice President & General Manager-Nephrology at Genzyme Corp.
from 2000 to 2012; and Chief Commercial Officer & Executive VP at AMAG Pharmaceuticals, Inc. from 2013 to 2014.
Education includes undergraduate studies at the University of Massachusetts.

Actieve functies van Gregory Madison

BedrijvenFunctieBegin
PROKIDNEY CORP. Corporate Officer/Principal 25-03-2026
Directeur/Bestuurslid -
Directeur/Bestuurslid 18-06-2021

Eerdere bekende functies van Gregory Madison

BedrijvenFunctieEinde
SHIELD THERAPEUTICS PLC Algemeen Directeur 24-07-2024
KERYX BIOPHARMACEUTICALS Algemeen Directeur 30-04-2018
Directeur/Bestuurslid 30-09-2014
AMAG PHARMACEUTICALS, INC. Corporate Officer/Principal 07-02-2014
Corporate Officer/Principal 01-01-2012
Ervaring van Gregory Madison in detail bekijken

Opleiding van Gregory Madison

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

77

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit10

Health Technology

Health Technology

Consumer Services

Health Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Gregory Madison